Brca1 Mutation Carrier Recruiting Phase 1 Trials for Veliparib (DB07232)

Also known as: BRCA1 Mutation Carrier

IndicationStatusPhase
DBCOND0030677 (Brca1 Mutation Carrier)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01434316Veliparib and Dinaciclib in Treating Patients With Advanced Solid TumorsTreatment